Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 1;207(5):506-508.
doi: 10.1164/rccm.202209-1769ED.

Screening for Preclinical Pulmonary Fibrosis: Are We There Yet?

Bridget F Collins  1
Affiliations
Editorial

Screening for Preclinical Pulmonary Fibrosis: Are We There Yet?

Bridget F Collins. Am J Respir Crit Care Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Incidence and Progression of Fibrotic Lung Disease in an At-Risk Cohort.
    Steele MP, Peljto AL, Mathai SK, Humphries S, Bang TJ, Oh A, Teague S, Cicchetti G, Sigakis C, Kropski JA, Loyd JE, Blackwell TS, Brown KK, Schwarz MI, Warren RA, Powers J, Walts AD, Markin C, Fingerlin TE, Yang IV, Lynch DA, Lee JS, Schwartz DA. Steele MP, et al. Am J Respir Crit Care Med. 2023 Mar 1;207(5):587-593. doi: 10.1164/rccm.202206-1075OC. Am J Respir Crit Care Med. 2023. PMID: 36094461 Free PMC article.

References

    1. Wijsenbeek M, Cottin V. Spectrum of fibrotic lung diseases. N Engl J Med . 2020;383:958–968. - PubMed
    1. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med . 2022;205:e18–e47. - PMC - PubMed
    1. Wells AU, Flaherty KR, Brown KK, Inoue Y, Devaraj A, Richeldi L, et al. INBUILD trial investigators Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Lancet Respir Med . 2020;8:453–460. - PubMed
    1. Hunninghake GM, Quesada-Arias LD, Carmichael NE, Martinez Manzano JM, Poli De Frías S, Baumgartner MA, et al. Interstitial lung disease in relatives of patients with pulmonary fibrosis. Am J Respir Crit Care Med . 2020;201:1240–1248. - PMC - PubMed
    1. Cutting CC, Bowman WS, Dao N, Pugashetti JV, Garcia CK, Oldham JM, et al. Family history of pulmonary fibrosis predicts worse survival in patients with interstitial lung disease. Chest . 2021;159:1913–1921. - PMC - PubMed

LinkOut - more resources